Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Anal Chem ; 94(18): 6760-6770, 2022 05 10.
Article in English | MEDLINE | ID: mdl-35467835

ABSTRACT

The accurate detection of nucleic acids from certain biological pathogens is critical for the diagnosis of human diseases. However, amplified detection of RNA molecules from a complex sample by direct detection of RNA/DNA hybrids remains a challenge. Here, we show that type IIS endonuclease FokI is able to digest DNA duplexes and DNA/RNA hybrids when assisted by a dumbbell-like fluorescent sensing oligonucleotide. As proof of concept, we designed a battery of sensing oligonucleotides against specific regions of the SARS-CoV-2 genome and interrogated the role of FokI relaxation as a potential nicking enzyme for fluorescence signal amplification. FokI-assisted digestion of SARS-CoV-2 probes increases the detection signal of ssDNA and RNA molecules and decreases the limit of detection more than 3.5-fold as compared to conventional molecular beacon approaches. This cleavage reaction is highly specific to its target molecules, and no detection of other highly related B-coronaviruses was observed in the presence of complex RNA mixtures. In addition, the FokI-assisted reaction has a high multiplexing potential, as the combined detection of different viral RNAs, including different SARS-CoV-2 variants, was achieved in the presence of multiple combinations of fluorophores and sensing oligonucleotides. When combined with isothermal rolling circle amplification technologies, FokI-assisted digestion reduced the detection time of SARS-CoV-2 in COVID-19-positive human samples with adequate sensitivity and specificity compared to conventional reverse transcription polymerase chain reaction approaches, highlighting the potential of FokI-assisted signal amplification as a valuable sensing mechanism for the detection of human pathogens.


Subject(s)
COVID-19 , SARS-CoV-2 , COVID-19/diagnosis , DNA , Digestion , Humans , Nucleic Acid Amplification Techniques , Oligonucleotides , RNA, Viral/genetics , SARS-CoV-2/genetics , Sensitivity and Specificity
2.
Int J Cancer ; 146(2): 373-387, 2020 01 15.
Article in English | MEDLINE | ID: mdl-31211412

ABSTRACT

Loss of 5-hydroxymethylcytosine (5hmC) has been associated with mutations of the ten-eleven translocation (TET) enzymes in several types of cancer. However, tumors with wild-type TET genes can also display low 5hmC levels, suggesting that other mechanisms involved in gene regulation might be implicated in the decline of this epigenetic mark. Here we show that DNA hypermethylation and loss of DNA hydroxymethylation, as well as a marked reduction of activating histone marks in the TET3 gene, impair TET3 expression and lead to a genome-wide reduction in 5hmC levels in glioma samples and cancer cell lines. Epigenetic drugs increased expression of TET3 in glioblastoma cells and ectopic overexpression of TET3 impaired in vitro cell growth and markedly reduced tumor formation in immunodeficient mice models. TET3 overexpression partially restored the genome-wide patterns of 5hmC characteristic of control brain samples in glioblastoma cell lines, while elevated TET3 mRNA levels were correlated with better prognosis in glioma samples. Our results suggest that epigenetic repression of TET3 might promote glioblastoma tumorigenesis through the genome-wide alteration of 5hmC.


Subject(s)
Brain Neoplasms/genetics , Carcinogenesis/genetics , Dioxygenases/genetics , Epigenesis, Genetic , Gene Expression Regulation, Neoplastic , Glioblastoma/genetics , 5-Methylcytosine/analogs & derivatives , 5-Methylcytosine/metabolism , Animals , Biopsy , Brain Neoplasms/mortality , Brain Neoplasms/pathology , Cell Line, Tumor , DNA Methylation , Down-Regulation , Glioblastoma/mortality , Glioblastoma/pathology , Histone Code/genetics , Humans , Mice , Prognosis , RNA, Messenger/metabolism , Survival Analysis , Xenograft Model Antitumor Assays
3.
Epigenetics ; 13(1): 95-107, 2018.
Article in English | MEDLINE | ID: mdl-29235922

ABSTRACT

Patterns of DNA methylation, an important epigenetic modification involved in gene silencing and development, are disrupted in cancer cells. Understanding the functional significance of aberrant methylation in tumors remains challenging, due in part to the lack of suitable tools to actively modify methylation patterns. DNA demethylation caused by mammalian DNA methyltransferase inhibitors is transient and replication-dependent, whereas that induced by TET enzymes involves oxidized 5mC derivatives that perform poorly understood regulatory functions. Unlike animals, plants possess enzymes that directly excise unoxidized 5mC from DNA, allowing restoration of unmethylated C through base excision repair. Here, we show that expression of Arabidopsis 5mC DNA glycosylase DEMETER (DME) in colon cancer cells demethylates and reactivates hypermethylated silenced loci. Interestingly, DME expression causes genome-wide changes that include both DNA methylation losses and gains, and partially restores the methylation pattern observed in normal tissue. Furthermore, such methylome reprogramming is accompanied by altered cell cycle responses and increased sensibility to anti-tumor drugs, decreased ability to form colonospheres, and tumor growth impairment in vivo. Our study shows that it is possible to reprogram a human cancer DNA methylome by expression of a plant DNA demethylase.


Subject(s)
Arabidopsis Proteins/genetics , Colonic Neoplasms/drug therapy , Colonic Neoplasms/genetics , DNA Methylation , N-Glycosyl Hydrolases/genetics , Trans-Activators/genetics , Animals , Antineoplastic Agents/pharmacology , Arabidopsis Proteins/metabolism , Cell Cycle/drug effects , Cell Cycle/genetics , Cell Line, Tumor , Colonic Neoplasms/pathology , DNA Repair/genetics , Fluorouracil/pharmacology , Gene Expression Regulation, Neoplastic , Genes, Tumor Suppressor , Genes, p16 , Humans , Mice, Nude , N-Glycosyl Hydrolases/metabolism , Oncogene Proteins/genetics , Oxaliplatin/pharmacology , Receptor Tyrosine Kinase-like Orphan Receptors/genetics , Trans-Activators/metabolism , Transgenes , Xenograft Model Antitumor Assays
SELECTION OF CITATIONS
SEARCH DETAIL
...